Oluwasola Olamikan, MD
Anesthesiology · Longview, WANPI 1679730204
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,150 of the $5,817 with a category attached, or 88.5%. 18 manufacturers reported payments, led by Abbott at 29.3% of the total. Reporting peaked in 2023 at $1,512 and has fallen 69.4% since, to $463 in 2025. Among anesthesiology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 175 payments — averaging $33.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$1K
- Nevro Corp.$1K
- AbbVie$339
- Boston Scientific$154
- GRT US Holding, Inc.$153
- plus $774 from 12 others
What the payments were for
- Travel & lodging$60410%
- Food & beverage$5,15089%
- Education$631%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 75 | $1,706 |
| Medtronic | 33 | $1,493 |
| Nevro Corp. | 20 | $1,199 |
| AbbVie | 11 | $339 |
| Boston Scientific | 4 | $154 |
| GRT US Holding, Inc. | 4 | $153 |
| Globus Medical | 1 | $142 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $136 |
| Pfizer | 6 | $114 |
| Averitas Pharma Inc. | 4 | $97 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| Si-bone, Inc. | 3 | $51 |
| Upsher-smith Laboratories LLC | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Novo Nordisk | 1 | $31 |
| Merz Pharmaceuticals, LLC | 1 | $29 |
| Vertex | 1 | $20 |
| MDD US Operations, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$1,040
- Senza Spinal Cord Stimulation System$723
- Senza$142
- PROCLAIM$133
- Accurian$121
- NT1100 NT2000iX Simplicity$118
- VRAYLAR$116
- OCTRODE$107
- Qutenza$105
- LUCEMYRA$100
How this compares
$5,817 in reported general payments places this provider in the 95th percentile of 1,206 anesthesiology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 13 | $86 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Longview
- David AuyongSeattle$284K
- Lucy HostetterSeattle$96K
- Georg MackensenSeattle$81K
- Ata-Ul RahmanSeattle$59K
- Cong YuSeattle$56K
- Deborah MerrillSeattle$37K
- Scott SpendloveSpokane Valley$32K
- David StoutSeattle$31K
- Cassie GabrielVancouver$29K
- Wenyu PanSeattle$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.